DEFER:

• For 4 months from date of full recovery and conclusion of treatment

 PERMANENTLY EXCLUDE:

• If donor has on-going symptoms
• If donor has a chronic infection

 SEXUAL CONTACT WITH INFECTED PERSON

 DEFER:

• For 4 months from conclusion of treatment if the donor was not clinically diagnosed with NSU following sexual contact, but was treated empirically
• For 4 months from the last sexual contact with infected person, if the donor did not require treatment for NSU following sexual contact
• For 4 months from date of full recovery and conclusion of treatment of infected person, if the donor did not require treatment for NSUfollowing sexual contact and the contact is on-going 

PERMANENTLY EXCLUDE:

• If the donor did not require treatment for NSUfollowing sexual contact and the contact is on-going, and the infected person has on-going symptoms or a chronic infection, permanently exclude the donor
• The donor may be accepted after the infected person is fully recovered. This must be at least 4 months after theinfected person contracted the infection 

ADDITIONAL INFORMATION

Urethritis is inflammation of the urethra. It is usually caused by infection, although this is not always the case. The term non-specific urethritis (NSU) is used when the cause of the urethritis has not yet been identified, but it is known that gonorrhea, is not responsible. NSU can have a number of possible causes, but it is estimated that the STI chlamydia is responsible for nearly half of all male cases in Ireland (www.hse.ie). NSU is usually treated with antibiotics and the symptoms usually resolve within two weeks. It is important that past and current sexual partners are also treated to prevent any infection spreading to other people. Women often have no symptoms of NSU, but if it is caused by chlamydia it can lead to pelvic inflammatory disease (PID) if it is not treated. Donors with a diagnosis or risk of NSU may pose a threat to the recipient safety if a donation was accepted